The Precision Peptide Genetic Test offered by PlexusDx evaluates how genetic variants in pathways like GLP1R (rs6923761) and MC4R (rs17782313) influence medication response and metabolic regulation
The preliminary results possibly indicated a weight increase and a potential rise in tibial and vertebral bone mineral content (BMC) with Ipamorelin, as observed by DXA, compared to the placebo
The overall risk in terms of how many people are potentially affected is still very small, says Dr
However, injectable Neurobion should only be used in pregnant women if clearly needed and prescribed by a doctor after weighing the potential benefits and risks
In addition to activating the GIP and GLP-1 receptors like tirzepatide, retatrutide also activates the glucagon receptor making it the first compound of its kind to reach late-stage clinical development for obesity and related metabolic conditions
doi: 10.1152/ajpregu.00520.2015 7 InoueTInoguchiTSonodaNHendartoHMakimuraHSasakiSet al
